GlassScriptPhysician profile
Ashley Robin Chandler
NPI 1225337926
$14,316.90
in general payments reported to CMS, 2019-2025
16 companies · $2,407 in 2025
The $2,407 reported for 2025 was more than what 87% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $962 · 2021: $34.37 · 2022: $478 · 2023: $823 · 2024: $9,102 · 2025: $2,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,169 · Travel and Lodging: $3,547 · Food and Beverage: $2,615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,168.75 |
| Travel and Lodging | $3,547.49 |
| Food and Beverage | $2,614.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $11,627.05 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Kci USA, INC. | $940.18 | 2019-2020 | |
| Musculoskeletal Transplant Foundation INC. | $528.59 | 2020-2025 | |
| Mentor Worldwide LLC | $464.14 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $338.87 | 2021-2022 | |
| Integra Lifesciences Corporation | $85.31 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Galderma Laboratories, L.P. | $70.02 | 2019-2020 | |
| Revance Therapeutics, INC. | $56.50 | 2024-2025 | Daxxify |
| Sientra, INC. | $39.34 | 2019 | |
| Tela Bio, INC. | $37.53 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Polarityte, INC. | $34.58 | 2019 | |
| Motiva USA, LLC | $26.34 | 2025 | |
| Acell, INC. | $22.07 | 2019 | |
| Zimmer Biomet Holdings, INC. | $18.50 | 2019 | |
| Apyx Medical Corporation | $14.63 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $13.25 | 2023 | Xeomin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Chandler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.